Commercialisation Seminar Series
How to identify potential commercial ideas and IP +
Making the most out of accelerator programs like CSIRO ON Prime
Thursday 16th March 2023
Andy Lamb, Director of Innovation Studios and Program Facilitator, Designer and Mentor of the CSIRO ON Prime program
 | For our first Commercialisation Seminar of 2023, we are thrilled to host Andy Lamb, a thought leader in innovation, entrepreneurship, and creative. Andy is the current Director of Innovation Studios and also a Program Facilitator, Designer and Mentor of the CSIRO ON Prime program. Previously the founder and CEO at Atomic Sky and consulting for clients such as CSIRO, Bankwest, CISCO, UWA, Curtin and the City of Perth, Andy has a track record setting up, running and working with successful businesses. An Entrepreneur in Residence of Tech Hub, a mentor for Founder Institute and a member of the Perth Angels investor network. Andy’s approach is all about disruption: he challenges organisations to look at what they’re building and whether this matches a genuine need. In this way, he works with companies willing to think outside the box to innovate and avoid waste. He looks at the specific culture and what will work in creating change there. He utilises a consideration of space, visual representations and models, creative tools and a human-centred approach to design thinking. This presentation will cover how to identify potential commercial ideas and IP within your research, specifically how it solves a problem and society and how to capture the novel aspects to gain investment. Andy will also speak about his experience with the CSIRO ON Prime program, and how to make the most of this, and other, accelerator programs. |
Past Seminars
Market Access for Innovative Technologies: Registration and Reimbursement | 9th September 2022
Eugene Salole (Principal, Value-Based Access) | Adjunct Professor, Faculty of Medicine, UNSW
 | We are pleased to welcome Eugene Salole, a Principal at Value-Based Access (a consultancy firm specialising in market access for innovative health technologies) and an Adjunct Professor at the Faculty of Medicine at University of New South Wales, to present this webinar. He is an experienced health technology assessment specialist, having held Australian and Asia-Pacific regional market access position in multinational medical device and pharmaceuticals companies prior to founding Value-Based Access. This presentation will focus on providing an overview of what scientists looking to commercialise a medical technology should be considering from the outset; to ultimately secure registration (through Government bodies such as the Therapeutic Goods Administrations) and reimbursement (through public and private systems such as Medicare and health insurers, respectively). |
Securing Venture Capital Investment for Your Research | 23rd June 2022
Prashanth Rajan, Investment Analyst at Brandon Capital Partners
We were fortunate to have Prashanth Rajan, an Investment Analyst at Brandon Capital Partners (a premier Australian venture capital firm), deliver this webinar. Prior to joining the world of venture capital, Prashanth was a Senior Commercialisation Manager at UniSA Ventures, the commercialisation and investment-management arm of the University of South Australia. Prashanth managed a portfolio of IP commercialisation projects and conducted several complex IP transactions. Prashanth was also the Operations Manager for AbRegen, a UniSA Ventures investee company, where he provided strategic leadership to the company and helped secure funding from the EB Research Partnership to further the preclinical program.
This presentation provided an overview of what venture capital is, elucidated insights into what venture capital look for in prospective healthcare investment opportunities, detail case studies of what Brandon Capital Partners have invested in and why, and described some best practices of how scientists and their respective commercialisation staff can prepare themselves to engage with venture capital.
Note this webinar was not recorded
Partnering with a Pharmaceutical Company | 2nd June 2022
Kathy Connell, Senior Director of External Innovation Partnering across Australia and New Zealand for Johnson and Johnson Innovation [This session was not recorded]
It was our pleasure to welcome Kathy Connell, the Senior Director of External Innovation Partnering across Australia and New Zealand for Johnson and Johnson Innovation, to present this webinar. Kathy has a clinical background and started her commercial career as the Vice President of Global Business Development for an Australian biotechnology company. Prior to joining Johnson and Johnson, Kathy worked for Sanofi where she engaged in in-licensing late-stage pharmaceutical assets.
This seminar focussed on the partnership of pharmaceutical companies with scientists and their respective medical research institutions. Kathy explored what she looks for in a potential partnering opportunities, how scientists and their commercialisation staff can engage a pharmaceutical company such as Johnson and Johnson (as well as some best practices), and several case studies of successful partnering arrangements within the Australian ecosystem.
Note this webinar was not recorded
Researcher Turned Entrepreneur | 28th April 2022
Matt Boustred, CEO of ResusRight
We were fortunate to welcome Matt Boustred, the CEO of ResusRight and current PhD Candidate in Biomedical Engineering at University of Sydney, to deliver our first seminar of the year. ResusRight was founded in 2020 with a mission to improve outcomes for infants that need resuscitation at birth, through the creation of technology that empowers clinicians to deliver high-quality care.
Matt described his journey to date, exploring the tension between being an academic researcher and leading a business, detailing what ResusRight is currently doing and its long-term vision, as well as provide advice to scientists seeking to explore a similar path.